谷歌浏览器插件
订阅小程序
在清言上使用

Safety and Clinical Effectiveness of Peginterferon Beta-1A for Relapsing Multiple Sclerosis in the Real-World Setting: Interim Results from the Plegridy Observational Program.

MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL(2024)

引用 0|浏览0
暂无评分
关键词
Multiple sclerosis,Peginterferon beta-1a,Real-world data,Safety,Effectiveness
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要